CliffBio
small molecule

EVEKEO ODT

AMPHETAMINE SULFATE

Loss of exclusivityMarch 2037latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameEVEKEO ODT
Active ingredientAMPHETAMINE SULFATE
Strength5MG
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2019
Marketing statusDISCN

Listed patents

PatentExpiresType
11896562March 2037use U-3299
10441554March 2037product
11160772March 2037product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EVEKEO ODT patent cliff — loss of exclusivity March 2037 | CliffBio